Ulisse Biomed SpA (MIL:UBM) Net Issuance of Preferred Stock : €0.00 Mil (TTM As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Ulisse Biomed SpA Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Ulisse Biomed SpA's net issuance of preferred for the six months ended in Dec. 2024 was €0.00 Mil. The number is 0, which means that Ulisse Biomed SpA has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Ulisse Biomed SpA's net issuance of preferred for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00 Mil.

Ulisse Biomed SpA Net Issuance of Preferred Stock Historical Data

The historical data trend for Ulisse Biomed SpA's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ulisse Biomed SpA Net Issuance of Preferred Stock Chart

Ulisse Biomed SpA Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Issuance of Preferred Stock

Get a 7-Day Free Trial

Ulisse Biomed SpA Semi-Annual Data
	Dec18	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Net Issuance of Preferred Stock	Get a 7-Day Free Trial						-	-	-	-	-

Ulisse Biomed SpA Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

Ulisse Biomed SpA Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Ulisse Biomed SpA's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Ulisse Biomed SpA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ulisse Biomed SpA (MIL:UBM) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

Area Science Park - SS14 km.163, 5, Basovizza, ITA, 34149

Website

https://www.ulissebiomed.com

Ulisse Biomed SpA is a healthcare biotech company. It is engaged in developing medical diagnostics, theranostics, and therapeutics solutions. The company has three technology platforms, namely, Sagitta for molecular diagnostics, NanoHybrid for theranostics and diagnostics, and Aptavir for therapeutics.

Ulisse Biomed SpA Headlines

No Headlines